Fluoropolymer Barrier Films and High-Performance Pharmaceutical Packaging Materials Market by Material Type (Fluoropolymers, Other High Barrier Materials), by Product Type (Flexible Pharmaceutical Packaging Structures, Sterile & High-Performance Packaging Materials), by Technology (Film Manufacturing & Conversion Technology, Barrier Enhancement Technology), by Application (Injectable & Parenteral Drug Packaging, Pharmaceutical Barrier & Containment Applications, Flexible Pharmaceutical Packaging Applications, Biopharmaceutical & Advanced Healthcare Applications), by Barrier Performance [Moisture Barrier, Oxygen Barrier, Chemical Resistance Barrier, UV & Light Barrier, Aroma & Volatile Organic Compound (VOC) Barrier, Sterile & Microbial Barrier, Extractables & Leachable Resistant Barrier, High-Purity/Inert Barrier], by Drug Type (Small Molecule Drugs, Biologics, Biosimilars, Vaccines, Cell and Gene Therapies, Hormonal Drugs, Oncology Drugs, High-Potency & Sensitive Drug Formulations), by End User (Pharmaceutical Manufacturers, Biopharmaceutical Companies, CDMOs/CMOs, Vaccine Manufacturers, Medical Device), by Packaging Format (Vials, Ampoules, Prefilled Syringes, Cartridges, IV Bags, Blister Packs, Fle), by Functionality (Sterility Protection, Chemical Resistance, Shelf-Life Extension, Contamination Prevention, Drug Stability Enhancement, High-Purity Containment), and by Region (North America, Europe, Asia Pacific, South America, MEA) Research Report Forecast till 2035

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ............... 33 2 MARKET INTRODUCTION ............ 36 2.1 DEFINITION .................. 36 2.2 SCOPE OF THE STUDY ...................... 36 2.3 RESEARCH OBJECTIVE .................... 36 2.4 MARKET STRUCTURE ...................... 37 3 RESEARCH METHODOLOGY ...... 39 3.1 OVERVIEW .................... 39 3.2 DATA FLOW .................. 41 3.2.1 DATA MINING PROCESS ......... 41 3.3 PURCHASED DATABASE: ................. 42 3.4 SECONDARY SOURCES: .................... 43 3.4.1 SECONDARY RESEARCH DATA FLOW: ............. 44 3.5 PRIMARY RESEARCH: ....................... 45 3.5.1 PRIMARY RESEARCH DATA FLOW: .................. 46 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ................... 47 3.6.1 REVENUE ANALYSIS APPROACH ..................... 47 3.7 DATA FORECASTING......................... 48 3.7.1 DATA FORECASTING TECHNIQUE .................... 48 3.8 DATA MODELING ........ 49 3.8.1 MICROECONOMIC FACTOR ANALYSIS: ............ 49 3.8.2 DATA MODELING: ................... 50 3.9 TEAMS AND ANALYST CONTRIBUTION ........... 51 4 MARKET DYNAMICS .................... 52 4.1 INTRODUCTION ........... 52 4.2 DRIVERS ......................... 53 4.2.1 GROWING DEMAND FOR HIGH-BARRIER PACKAGING TO EXTEND SHELF LIFE OF SENSITIVE MEDICINES INCLUDING BIOLOGICS ................. 53 4.2.2 RISING ADOPTION OF FLUOROPOLYMER-BASED MATERIALS IN BLISTER AND SECONDARY PACKAGING TO IMPROVE MOISTURE AND OXYGEN PROTECTION ........................ 54 4.2.3 EXPANSION OF PHARMACEUTICAL PRODUCTION AND COLD-CHAIN LOGISTICS INCREASING NEED FOR DURABLE, COMPLIANT PACKAGING .................... 54 4.2.4 DRIVERS IMPACT ANALYSIS ........................... 55 4.3 RESTRAINTS ................ 55 4.3.1 HIGH MATERIAL AND CONVERSION COSTS OF FLUOROPOLYMER FILMS COMPARED WITH CONVENTIONAL PACKAGING OPTIONS ......................... 55 4.3.2 STRICT REGULATORY REQUIREMENTS AND COMPLEX VALIDATION FOR PHARMACEUTICAL PACKAGING CAN SLOW COMMERCIALIZATION AND LIMIT PRODUCT CHANGES........................ 56 4.4 OPPORTUNITIES ......... 57 4.4.1 INCREASED OPPORTUNITIES IN EMERGING MARKETS AS NEW PHARMACEUTICAL CAPACITY DRIVES DEMAND FOR ADVANCED PACKAGING PERFORMANCE ..................... 57 4.4.2 DEVELOPMENT OF RECYCLABLE AND LOWER-IMPACT FLUOROPOLYMER BARRIER SOLUTIONS TO MEET SUSTAINABILITY GOALS AND CUSTOMER REQUIREMENTS .................. 58 4.5 CHALLENGES ............... 58 4.5.1 SUPPLY CHAIN VOLATILITY FOR SPECIALTY FLUOROPOLYMER FEEDSTOCKS AND POTENTIAL DISRUPTIONS AFFECTING FILM AVAILABILITY AND LEAD TIMES ....... 58 4.5.2 SUBSTITUTION RISK FROM ALTERNATIVE HIGH-BARRIER POLYMERS AND MULTILAYER FILM TECHNOLOGIES WITH COMPETITIVE PRICING ....................... 59 5 MARKET FACTOR ANALYSIS ...... 60 5.1 SUPPLY/ VALUE CHAIN ANALYSIS .................... 60 5.1.1 RAW MATERIAL/MATERIALS PROVIDERS ........ 61 5.1.2 MANUFACTURERS .................. 62 5.1.3 DISTRIBUTION ........................ 62 5.1.4 KEY END-USERS...................... 62 5.2 VALUE PERCOLATION ACROSS THE CHAIN .... 63 5.3 INTEGRATION LEVELS ..................... 63 5.3.1 DEGREE OF VERTICAL AND HORIZONTAL INTEGRATION AMONG OEMS, DISTRIBUTORS, AND SERVICE PROVIDERS 63 5.4 KEY ISSUES ADDRESSED ................. 64 5.4.1 SUPPLY STABILITY, REGULATORY COMPLIANCE, AND SUSTAINABILITY CHALLENGES ............. 64 5.5 PORTER’S FIVE FORCES MODEL ........................... 65 5.5.1 BARGAINING POWER OF SUPPLIERS ............... 65 5.5.2 BARGAINING POWER OF BUYERS .................... 66 5.5.3 THREAT OF NEW ENTRANTS ........................... 66 5.5.4 THREAT OF SUBSTITUTES ...... 66 5.5.5 INTENSITY OF RIVALRY .......... 67 5.6 TECHNOLOGICAL ADVANCEMENTS ................... 67 5.7 ADJACENT MARKET ANALYSIS .......................... 68 5.8 REGULATORY FRAMEWORK ......... 69 5.8.1 GOVERNMENT POLICIES ......... 69 5.8.2 ENVIRONMENTAL CONSIDERATION ................ 70 5.9 R & D UPDATE .............. 70 5.9.1 CURRENT SCENARIO .............. 70 5.9.2 FUTURE ROADMAP ................. 71 5.9.3 CHALLENGES ......................... 71 5.9.4 NOVEL APPLICATIONS ........... 71 5.9.5 KEY DEVELOPMENTS .............. 72 5.10 PESTLE ANALYSIS ..... 72 5.10.1 POLITICAL ..... 72 5.10.2 ECONOMICAL ......................... 73 5.10.3 SOCIAL .......... 73 5.10.4 TECHNOLOGICAL ................... 73 5.10.5 LEGAL ............ 74 5.10.6 ENVIRONMENTAL ................... 74 5.11 FLUOROPOLYMER MATERIAL INNOVATION & TECHNOLOGY ASSESSMENT ............ 74 5.11.1 INTRODUCTION ...................... 74 5.11.1.1 OVERVIEW OF FLUOROPOLYMER BARRIER MATERIALS ............... 74 5.11.1.2 IMPORTANCE OF HIGH-PERFORMANCE BARRIER FILMS IN PHARMA APPLICATIONS 75 5.11.1.3 ROLE OF FLUOROPOLYMERS IN CRITICAL STERILE PACKAGING ........................... 75 5.11.1.4 MATERIAL ANALYSIS ........... 75 5.12 EMERGING BARRIER TECHNOLOGIES ANALYSIS .................. 78 5.12.1 HIGH-BARRIER FILM TECHNOLOGY LANDSCAPE ...................... 78 5.12.1.1 EVOLUTION OF BARRIER PACKAGING TECHNOLOGIES ................ 78 5.12.1.2 DEMAND FOR ADVANCED PHARMA BARRIER SYSTEMS ............... 78 5.12.2 EMERGING BARRIER TECHNOLOGIES .............. 78 5.12.2.1 MULTILAYER BARRIER STRUCTURES ............... 78 5.12.2.2 ADVANCED COATING TECHNOLOGIES ............. 79 5.12.2.3 STERILE BARRIER INNOVATIONS ................... 79 5.12.2.4 SMART & FUNCTIONAL BARRIER PACKAGING ........................... 79 5.13 COMPETITIVE BENCHMARKING & ALTERNATIVE MATERIAL ASSESSMENT .......... 80 5.13.1 COMPETITIVE MATERIAL BENCHMARKING ..... 80 5.13.1.1 FLUOROPOLYMERS VS EVOH ......................... 80 5.13.1.2 FLUOROPOLYMERS VS COP/COC .................... 80 5.13.1.3 FLUOROPOLYMERS VS POLYAMIDE STRUCTURES ...................... 81 5.13.1.4 FLUOROPOLYMERS VS ALUMINUM FOIL LAMINATES .................. 81 5.13.2 TECHNOLOGY COMPARISON .......................... 82 5.13.2.1 BARRIER PERFORMANCE COMPARISON ........... 82 5.13.2.2 STERILITY & EXTRACTABLES PERFORMANCE ........................... 82 5.13.2.3 COST-TO-PERFORMANCE ANALYSIS ............... 83 5.13.2.4 SUSTAINABILITY COMPARISON ..................... 83 5.14 SUSTAINABILITY & REGULATORY TRENDS .... 84 5.14.1 SUSTAINABILITY TRENDS ....... 84 5.14.1.1 SUSTAINABLE PHARMA PACKAGING TRENDS ........................... 84 5.14.1.2 PFAS-RELATED DEVELOPMENTS .................... 84 5.14.1.3 SUSTAINABLE ALTERNATIVES ....................... 85 5.14.2 REGULATORY TRENDS ............ 85 5.14.2.1 GLOBAL REGULATORY FRAMEWORK ............... 85 5.14.2.2 EXTRACTABLES & LEACHABLES REGULATIONS ......................... 85 5.14.2.2.1 QUALIFICATION STANDARDS 85 5.14.2.2.2 Testing Requirements 86 5.14.2.2.3 Sterility Validation 86 5.15 STRATEGIC OPPORTUNITY & GO-TO-MARKET ANALYSIS ........................ 86 5.15.1 PRODUCT INNOVATION OPPORTUNITIES ........ 86 5.15.2 TECHNOLOGY ADOPTION TRENDS .................. 87 5.15.3 PARTNERSHIP & COLLABORATION OPPORTUNITIES ................ 87 5.15.4 COMPETITIVE DIFFERENTIATION STRATEGIES ........................ 88 5.15.5 REGIONAL EXPANSION OPPORTUNITIES ......... 88 5.15.6 CUSTOMER DEMAND ASSESSMENT ................ 88 5.15.7 COMMERCIALIZATION & GO-TO-MARKET STRATEGY ............... 89 5.16 WHITE-SPACE OPPORTUNITY & INVESTMENT ANALYSIS ....................... 89 5.16.1 WHITE-SPACE OPPORTUNITY ANALYSIS ......... 89 5.16.1.1 UNTAPPED APPLICATION AREAS ................... 89 5.16.1.2 UNDERPENETRATED PHARMA SEGMENTS ........ 90 5.16.1.3 EMERGING TECHNOLOGY GAPS ..................... 90 5.16.2 UNTAPPED REGIONAL DEMAND ...................... 90 5.16.2.1 HIGH-GROWTH COUNTRIES ........................... 90 5.16.2.2 REGIONAL SUPPLY GAPS ..... 91 5.16.2.3 DEMAND-SUPPLY IMBALANCES ..................... 91 5.16.3 EMERGING CUSTOMER REQUIREMENTS .......... 92 5.16.4 STRATEGIC INVESTMENT AREAS .................... 92 5.16.5 ACQUISITION & PARTNERSHIP OPPORTUNITIES ...................... 92 5.16.5.1 POTENTIAL TECHNOLOGY ACQUISITION TARGETS .................... 92 5.16.5.2 STRATEGIC PACKAGING PARTNERSHIPS ......... 93 5.16.5.3 EMERGING INNOVATOR IDENTIFICATION ......... 93 5.17 FLUOROPOLYMER APPLICATION & PENETRATION ANALYSIS ............... 94 5.17.1 PHARMA APPLICATION ASSESSMENT ............ 94 5.17.2 PENETRATION ANALYSIS ....... 95 5.17.3 SUPPLY-DEMAND ANALYSIS ........................... 95 5.17.4 INDUSTRY ECOSYSTEM & VALUE CREATION .... 96 5.18 PRICING ANALYSIS.... 97 5.18.1 PRICING OVERVIEW ................ 97 5.18.2 MATERIAL-WISE PRICING ANALYSIS ............... 98 5.18.3 APPLICATION-WISE PRICING .......................... 98 5.18.4 SUPPLY CHAIN COST ANALYSIS ..................... 99 5.18.5 MARGIN & PROFITABILITY ANALYSIS .............. 99 5.18.6 FUTURE PRICING OUTLOOK .... 99 6 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE ............... 100 6.1 INTRODUCTION ........... 100 6.2 FLUOROPOLYMERS ........................... 101 6.2.1 PTFE (POLYTETRAFLUOROETHYLENE) ............ 101 6.2.2 ETFE (ETHYLENE TETRAFLUOROETHYLENE) ........................... 102 6.2.3 FEP (FLUORINATED ETHYLENE PROPYLENE) ........................... 102 6.2.4 PFA (PERFLUOROALKOXY ALKANE) ................ 102 6.2.5 PVDF (POLYVINYLIDENE FLUORIDE) ................ 102 6.2.6 ECTFE (ETHYLENE CHLOROTRIFLUOROETHYLENE) ................. 102 6.2.7 THV FLUOROPOLYMERS ......... 102 6.2.8 FLUOROELASTOMERS ............ 102 6.3 OTHER HIGH BARRIER MATERIALS ................... 102 6.3.1 EVOH (ETHYLENE VINYL ALCOHOL) ................ 103 6.3.2 COP/COC (CYCLIC OLEFIN POLYMER / CYCLIC OLEFIN COPOLYMER) .............. 103 6.3.3 POLYAMIDE ........................... 103 6.3.4 POLYETHYLENE ..................... 103 6.3.5 POLYPROPYLENE ................... 103 6.3.6 PVC (POLYVINYL CHLORIDE) .......................... 103 6.3.7 OTHERS ......... 103 7 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE ............... 104 7.1 INTRODUCTION ........... 104 7.2 BARRIER FILMS .......... 107 7.2.1 MONOLAYER BARRIER FILMS .......................... 107 7.2.2 MULTILAYER BARRIER FILMS .......................... 107 7.2.3 CO-EXTRUDED BARRIER FILMS ........................ 107 7.2.4 LAMINATED BARRIER FILMS ........................... 107 7.2.5 COATED HIGH-BARRIER FILMS ........................ 107 7.2.6 FLUOROPOLYMER BARRIER FILMS .................. 107 7.2.7 METALLIZED BARRIER FILMS .......................... 108 7.3 FLEXIBLE PHARMACEUTICAL PACKAGING STRUCTURES ....................... 108 7.3.1 BLISTER PACKAGING FILMS ........................... 108 7.3.2 BLISTER LIDDING FILMS ......... 108 7.3.3 SACHETS & STICK PACKS ....... 108 7.3.4 HIGH-BARRIER POUCHES ........ 108 7.3.5 STRIP PACKS ......................... 108 7.3.6 STERILE MEDICAL POUCHES ........................... 109 7.4 STERILE & HIGH-PERFORMANCE PACKAGING MATERIALS ..................... 109 7.4.1 BIOPHARMACEUTICAL PACKAGING FILMS ...... 109 7.4.2 STERILE BARRIER FILMS ......... 109 7.4.3 CHEMICAL-RESISTANT PACKAGING FILMS...... 109 7.4.4 HIGH-PURITY CONTAINMENT FILMS ............... 109 7.4.5 MEDICAL DEVICE PACKAGING FILMS .............. 109 8 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY .................. 110 8.1 INTRODUCTION ........... 110 8.2 FILM MANUFACTURING & CONVERSION TECHNOLOGY .... 111 8.2.1 EXTRUSION TECHNOLOGY ...... 111 8.2.2 CO-EXTRUSION TECHNOLOGY ........................ 111 8.2.3 BLOW FILM TECHNOLOGY ...... 112 8.2.4 CAST FILM TECHNOLOGY ....... 112 8.2.5 LAMINATION TECHNOLOGY .... 112 8.2.6 COATING & SURFACE TREATMENT TECHNOLOGY ................... 112 8.3 BARRIER ENHANCEMENT TECHNOLOGY ........ 112 8.3.1 BARRIER ENHANCEMENT TECHNOLOGY ......... 112 8.3.2 FLUOROPOLYMER BARRIER COATING ............. 112 8.3.3 PLASMA SURFACE COATING........................... 113 8.3.4 VAPOR DEPOSITION TECHNOLOGY ................. 113 8.3.5 METALLIZATION TECHNOLOGY ...................... 113 8.3.6 MULTILAYER BARRIER TECHNOLOGY .............. 113 8.3.7 NANOCOMPOSITE BARRIER TECHNOLOGY ...... 113 8.3.8 SIOX/ALOX BARRIER COATING TECHNOLOGY ......................... 113 9 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION .................... 114 9.1 INTRODUCTION ........... 114 9.2 INJECTABLE & PARENTERAL DRUG PACKAGING ................. 116 9.2.1 VACCINE PACKAGING............. 116 9.2.2 BIOLOGICS PACKAGING .......... 116 9.2.3 INJECTABLE DRUG PACKAGING ...................... 116 9.2.4 CELL & GENE THERAPY PACKAGING ............... 116 9.2.5 INFUSION & IV PACKAGING ..... 117 9.3 PHARMACEUTICAL BARRIER & CONTAINMENT APPLICATIONS ........... 117 9.3.1 STERILE DRUG CONTAINMENT ........................ 117 9.3.2 API & INTERMEDIATE PROTECTION ................. 117 9.3.3 MOISTURE-SENSITIVE DRUG PACKAGING ........ 117 9.3.4 OXYGEN-SENSITIVE DRUG PACKAGING ........... 117 9.3.5 CHEMICALLY REACTIVE DRUG PACKAGING ..... 117 9.3.6 LIGHT-SENSITIVE DRUG PACKAGING ............... 117 9.4 FLEXIBLE PHARMACEUTICAL PACKAGING APPLICATIONS .................... 118 9.4.1 BLISTER PACKAGING .............. 118 9.4.2 SACHETS & STICK PACKS ....... 118 9.4.3 HIGH-BARRIER POUCHES ........ 118 9.4.4 STRIP PACKAGING ................. 118 9.4.5 UNIT-DOSE PACKAGING .......... 118 9.5 BIOPHARMACEUTICAL & ADVANCED HEALTHCARE APPLICATIONS .......................... 118 9.5.1 SINGLE-USE BIOPROCESS SYSTEMS................ 119 9.5.2 BIOPROCESS BAGS & LINERS .......................... 119 9.5.3 STERILE FLUID TRANSFER SYSTEMS ............... 119 9.5.4 DIAGNOSTIC & MEDICAL DEVICE PACKAGING ......................... 119 9.5.5 HIGH-PURITY PHARMACEUTICAL PACKAGING......................... 119 10 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE ....................... 120 10.1 INTRODUCTION ........... 120 10.2 MOISTURE BARRIER ......................... 121 10.3 OXYGEN BARRIER ...... 122 10.4 CHEMICAL RESISTANCE BARRIER ...................... 122 10.5 UV & LIGHT BARRIER ........................ 122 10.6 AROMA & VOLATILE ORGANIC COMPOUND (VOC) BARRIER ..................... 122 10.7 STERILE & MICROBIAL BARRIER .......................... 123 10.8 EXTRACTABLES & LEACHABLES RESISTANT BARRIER ..... 123 10.9 HIGH-PURITY/INERT BARRIER ..... 123 11 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE ...................... 124 11.1 INTRODUCTION ........... 124 11.2 SMALL MOLECULE DRUGS ............. 125 11.3 BIOLOGICS ..................... 126 11.4 BIOSIMILARS ................ 126 11.5 VACCINES ..................... 126 11.6 CELL AND GENE THERAPIES ......... 126 11.7 HORMONAL DRUGS ........................... 127 11.8 ONCOLOGY DRUGS ..... 127 11.9 HIGH-POTENCY & SENSITIVE DRUG FORMULATIONS ......... 127 12 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER ......................... 128 12.1 INTRODUCTION ........... 128 12.2 PHARMACEUTICAL MANUFACTURERS ........... 129 12.3 BIOPHARMACEUTICAL COMPANIES .................. 130 12.4 CDMOS/CMOS .............. 130 12.5 VACCINE MANUFACTURERS ........ 130 12.6 MEDICAL DEVICE COMPANIES ..... 130 12.7 DIAGNOSTIC COMPANIES ............... 131 12.8 PACKAGING CONVERTERS ............. 131 12.9 HEALTHCARE INSTITUTIONS ....... 131 13 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT ...... 132 13.1 INTRODUCTION ........... 132 13.2 VIALS ...... 133 13.3 AMPOULES ................... 134 13.4 PREFILLED SYRINGES ...................... 134 13.5 CARTRIDGES ................ 134 13.6 IV BAGS .......................... 134 13.7 BLISTER PACKS .......... 135 13.8 FLEXIBLE POUCHES .......................... 135 13.9 STRIP PACKS................ 135 14 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY ............... 136 14.1 INTRODUCTION ........... 136 14.2 STERILITY PROTECTION ................. 138 14.3 CHEMICAL RESISTANCE ................. 138 14.4 SHELF-LIFE EXTENSION ................. 138 14.5 CONTAMINATION PREVENTION .......................... 138 14.6 DRUG STABILITY ENHANCEMENT ..................... 139 14.7 HIGH-PURITY CONTAINMENT ...... 139 15 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY REGION ..... 140 15.1 OVERVIEW .................... 140 15.2 NORTH AMERICA ....... 141 15.2.1 U.S................. 146 15.2.2 CANADA ........ 150 15.3 EUROPE .......................... 154 15.3.1 GERMANY ...... 158 15.3.2 FRANCE ......... 162 15.3.3 UK ................. 165 15.3.4 ITALY ............. 169 15.3.5 SPAIN ............ 173 15.3.6 REST OF EUROPE .................... 177 15.4 ASIA-PACIFIC ............... 181 15.4.1 CHINA ............ 185 15.4.2 INDIA ............. 189 15.4.3 JAPAN ........... 193 15.4.4 SOUTH KOREA ........................ 197 15.4.5 MALAYSIA ..... 201 15.4.6 THAILAND ...... 205 15.4.7 INDONESIA ..... 209 15.4.8 REST OF APAC ....................... 213 15.5 SOUTH AMERICA ....... 217 15.5.1 BRAZIL ........... 221 15.5.2 ARGENTINA ........................... 225 15.5.3 MEXICO ......... 229 15.5.4 REST OF SOUTH AMERICA ...... 233 15.6 MEA ......... 237 15.6.1 GCC COUNTRIES..................... 241 15.6.2 SOUTH AFRICA ....................... 245 15.6.3 REST OF MEA ......................... 249 16 COMPETITIVE LANDSCAPE ........ 253 16.1 INTRODUCTION ........... 253 16.2 COMPETITOR DASHBOARD............. 254 16.3 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL ...... 255 16.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF RECENT DEVELOPMENTS IN THE MARKET 255 16.5 KEY DEVELOPMENTS & GROWTH STRATEGIES .................... 256 16.5.1 PRODUCT INNOVATION .......... 256 16.5.2 AWARD .......... 256 16.5.3 ACQUISITION ......................... 257 16.5.4 EXPANSION ........................... 257 17 COMPANY PROFILES .................. 258 17.1 DAIKIN INDUSTRIES.......................... 258 17.1.1 COMPANY OVERVIEW ............. 258 17.1.2 FINANCIAL OVERVIEW ............ 259 17.1.3 PRODUCTS OFFERED .............. 259 17.1.4 KEY DEVELOPMENTS .............. 259 17.1.5 SWOT ANALYSIS .................... 260 17.1.6 KEY STRATEGIES .................... 260 17.2 SAINT-GOBAIN ............ 261 17.2.1 COMPANY OVERVIEW ............. 261 17.2.2 FINANCIAL OVERVIEW ............ 262 17.2.3 PRODUCTS OFFERED .............. 262 17.2.4 KEY DEVELOPMENTS .............. 262 17.2.5 SWOT ANALYSIS .................... 264 17.2.6 KEY STRATEGIES .................... 264 17.3 HONEYWELL INTERNATIONAL INC ................... 265 17.3.1 COMPANY OVERVIEW ............. 265 17.3.2 FINANCIAL OVERVIEW ............ 266 17.3.3 PRODUCTS OFFERED .............. 267 17.3.4 KEY DEVELOPMENTS .............. 267 17.3.5 SWOT ANALYSIS .................... 267 17.3.6 KEY STRATEGIES .................... 268 17.4 WEST PHARMACEUTICAL SERVICES, INC. ...... 269 17.4.1 COMPANY OVERVIEW ............. 269 17.4.2 FINANCIAL OVERVIEW ............ 270 17.4.3 PRODUCTS OFFERED .............. 270 17.4.4 KEY DEVELOPMENTS .............. 270 17.4.5 SWOT ANALYSIS .................... 271 17.4.6 KEY STRATEGIES .................... 271 17.5 ARKEMA ........................ 272 17.5.1 COMPANY OVERVIEW ............. 272 17.5.2 FINANCIAL OVERVIEW ............ 273 17.5.3 PRODUCTS OFFERED .............. 273 17.5.4 KEY DEVELOPMENTS .............. 273 17.5.5 SWOT ANALYSIS .................... 274 17.5.6 KEY STRATEGIES .................... 274 17.6 GUARNIFLON® S.P.A ......................... 275 17.6.1 COMPANY OVERVIEW ............. 275 17.6.2 FINANCIAL OVERVIEW ............ 275 17.6.3 PRODUCTS OFFERED .............. 275 17.6.4 KEY DEVELOPMENTS .............. 275 17.6.5 SWOT ANALYSIS .................... 276 17.6.6 KEY STRATEGIES .................... 276 17.7 TEKNI-PLEX, INC. ....... 277 17.7.1 COMPANY OVERVIEW ............. 277 17.7.2 FINANCIAL OVERVIEW ............ 277 17.7.3 PRODUCTS OFFERED .............. 277 17.7.4 KEY DEVELOPMENTS .............. 278 17.7.5 SWOT ANALYSIS .................... 278 17.7.6 KEY STRATEGIES .................... 278 17.8 ACG .......... 279 17.8.1 COMPANY OVERVIEW ............. 279 17.8.2 FINANCIAL OVERVIEW ............ 279 17.8.3 PRODUCTS OFFERED .............. 279 17.8.4 KEY DEVELOPMENTS .............. 279 17.8.5 SWOT ANALYSIS .................... 280 17.8.6 KEY STRATEGIES .................... 280 17.9 DUPONT ......................... 281 17.9.1 COMPANY OVERVIEW ............. 281 17.9.2 FINANCIAL OVERVIEW ............ 281 17.9.3 PRODUCTS OFFERED .............. 282 17.9.4 KEY DEVELOPMENTS .............. 282 17.9.5 SWOT ANALYSIS .................... 283 17.9.6 KEY STRATEGIES .................... 283 17.10 CAPRIHANS INDIA LIMITED .......... 284 17.10.1 COMPANY OVERVIEW ............. 284 17.10.2 FINANCIAL OVERVIEW ............ 284 17.10.3 PRODUCTS OFFERED .............. 285 17.10.4 KEY DEVELOPMENTS .............. 285 17.10.5 SWOT ANALYSIS .................... 285 17.10.6 KEY STRATEGIES .................... 286 17.11 DATA CITATIONS ....... 288

LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 50 TABLE 2 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 100 TABLE 3 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 104 TABLE 4 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 110 TABLE 5 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 114 TABLE 6 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 120 TABLE 7 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 124 TABLE 8 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 128 TABLE 9 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 132 TABLE 10 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 136 TABLE 11 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY REGION, 2021-2035 (USD MILLION) 140 TABLE 12 NORTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY COUNTRY, 2021-2035 (USD MILLION) 141 TABLE 13 NORTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 142 TABLE 14 NORTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 142 TABLE 15 NORTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 142 TABLE 16 NORTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 143 TABLE 17 NORTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 143 TABLE 18 NORTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 144 TABLE 19 NORTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 144 TABLE 20 NORTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 145 TABLE 21 NORTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 145 TABLE 22 U.S. FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 146 TABLE 23 U.S. FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 146 TABLE 24 U.S. FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 146 TABLE 25 U.S. FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 147 TABLE 26 U.S. FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 147 TABLE 27 U.S. FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 148 TABLE 28 U.S. FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 148 TABLE 29 U.S. FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 149 TABLE 30 U.S. FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 149 TABLE 31 CANADA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 150 TABLE 32 CANADA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 150 TABLE 33 CANADA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 150 TABLE 34 CANADA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 151 TABLE 35 CANADA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 151 TABLE 36 CANADA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 152 TABLE 37 CANADA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 152 TABLE 38 CANADA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 153 TABLE 39 CANADA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 153 TABLE 40 EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY COUNTRY, 2021-2035 (USD MILLION) 154 TABLE 41 EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 154 TABLE 42 EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 155 TABLE 43 EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 155 TABLE 44 EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 155 TABLE 45 EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 156 TABLE 46 EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 156 TABLE 47 EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 157 TABLE 48 EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 157 TABLE 49 EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 158 TABLE 50 GERMANY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 158 TABLE 51 GERMANY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 158 TABLE 52 GERMANY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 159 TABLE 53 GERMANY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 159 TABLE 54 GERMANY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 159 TABLE 55 GERMANY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 160 TABLE 56 GERMANY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 160 TABLE 57 GERMANY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 161 TABLE 58 GERMANY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 161 TABLE 59 FRANCE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 162 TABLE 60 FRANCE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 162 TABLE 61 FRANCE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 162 TABLE 62 FRANCE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 163 TABLE 63 FRANCE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 163 TABLE 64 FRANCE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 164 TABLE 65 FRANCE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 164 TABLE 66 FRANCE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 165 TABLE 67 FRANCE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 165 TABLE 68 UK FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 165 TABLE 69 UK FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 166 TABLE 70 UK FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 166 TABLE 71 UK FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 166 TABLE 72 UK FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 167 TABLE 73 UK FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 167 TABLE 74 UK FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 168 TABLE 75 UK FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 168 TABLE 76 UK FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 169 TABLE 77 ITALY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 169 TABLE 78 ITALY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 170 TABLE 79 ITALY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 170 TABLE 80 ITALY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 170 TABLE 81 ITALY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 171 TABLE 82 ITALY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 171 TABLE 83 ITALY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 172 TABLE 84 ITALY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 172 TABLE 85 ITALY FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 173 TABLE 86 SPAIN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 173 TABLE 87 SPAIN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 173 TABLE 88 SPAIN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 174 TABLE 89 SPAIN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 174 TABLE 90 SPAIN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 174 TABLE 91 SPAIN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 175 TABLE 92 SPAIN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 175 TABLE 93 SPAIN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 176 TABLE 94 SPAIN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 176 TABLE 95 REST OF EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 177 TABLE 96 REST OF EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 177 TABLE 97 REST OF EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 177 TABLE 98 REST OF EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 178 TABLE 99 REST OF EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 178 TABLE 100 REST OF EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 179 TABLE 101 REST OF EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 179 TABLE 102 REST OF EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 180 TABLE 103 REST OF EUROPE FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 180 TABLE 104 ASIA_PACIFIC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY COUNTRY, 2021-2035 (USD MILLION) 181 TABLE 105 ASIA_PACIFIC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 181 TABLE 106 ASIA_PACIFIC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 182 TABLE 107 ASIA_PACIFIC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 182 TABLE 108 ASIA_PACIFIC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 182 TABLE 109 ASIA_PACIFIC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 183 TABLE 110 ASIA_PACIFIC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 183 TABLE 111 ASIA_PACIFIC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 184 TABLE 112 ASIA_PACIFIC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 184 TABLE 113 ASIA_PACIFIC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 185 TABLE 114 CHINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 185 TABLE 115 CHINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 185 TABLE 116 CHINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 186 TABLE 117 CHINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 186 TABLE 118 CHINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 186 TABLE 119 CHINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 187 TABLE 120 CHINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 187 TABLE 121 CHINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 188 TABLE 122 CHINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 188 TABLE 123 INDIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 189 TABLE 124 INDIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 189 TABLE 125 INDIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 189 TABLE 126 INDIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 190 TABLE 127 INDIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 190 TABLE 128 INDIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 191 TABLE 129 INDIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 191 TABLE 130 INDIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 192 TABLE 131 INDIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 192 TABLE 132 JAPAN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 193 TABLE 133 JAPAN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 193 TABLE 134 JAPAN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 193 TABLE 135 JAPAN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 194 TABLE 136 JAPAN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 194 TABLE 137 JAPAN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 195 TABLE 138 JAPAN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 195 TABLE 139 JAPAN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 196 TABLE 140 JAPAN FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 196 TABLE 141 SOUTH KOREA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 197 TABLE 142 SOUTH KOREA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 197 TABLE 143 SOUTH KOREA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 197 TABLE 144 SOUTH KOREA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 198 TABLE 145 SOUTH KOREA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 198 TABLE 146 SOUTH KOREA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 199 TABLE 147 SOUTH KOREA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 199 TABLE 148 SOUTH KOREA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 200 TABLE 149 SOUTH KOREA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 200 TABLE 150 MALAYSIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 201 TABLE 151 MALAYSIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 201 TABLE 152 MALAYSIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 201 TABLE 153 MALAYSIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 202 TABLE 154 MALAYSIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 202 TABLE 155 MALAYSIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 203 TABLE 156 MALAYSIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 203 TABLE 157 MALAYSIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 204 TABLE 158 MALAYSIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 204 TABLE 159 THAILAND FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 205 TABLE 160 THAILAND FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 205 TABLE 161 THAILAND FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 205 TABLE 162 THAILAND FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 206 TABLE 163 THAILAND FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 206 TABLE 164 THAILAND FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 207 TABLE 165 THAILAND FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 207 TABLE 166 THAILAND FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 208 TABLE 167 THAILAND FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 208 TABLE 168 INDONESIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 209 TABLE 169 INDONESIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 209 TABLE 170 INDONESIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 209 TABLE 171 INDONESIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 210 TABLE 172 INDONESIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 210 TABLE 173 INDONESIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 211 TABLE 174 INDONESIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 211 TABLE 175 INDONESIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 212 TABLE 176 INDONESIA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 212 TABLE 177 REST OF APAC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 213 TABLE 178 REST OF APAC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 213 TABLE 179 REST OF APAC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 213 TABLE 180 REST OF APAC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 214 TABLE 181 REST OF APAC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 214 TABLE 182 REST OF APAC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 215 TABLE 183 REST OF APAC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 215 TABLE 184 REST OF APAC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 216 TABLE 185 REST OF APAC FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 216 TABLE 186 SOUTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY COUNTRY, 2021-2035 (USD MILLION) 217 TABLE 187 SOUTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 217 TABLE 188 SOUTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 217 TABLE 189 SOUTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 218 TABLE 190 SOUTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 218 TABLE 191 SOUTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 219 TABLE 192 SOUTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 219 TABLE 193 SOUTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 220 TABLE 194 SOUTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 220 TABLE 195 SOUTH AMERICA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 221 TABLE 196 BRAZIL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 221 TABLE 197 BRAZIL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 221 TABLE 198 BRAZIL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 222 TABLE 199 BRAZIL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 222 TABLE 200 BRAZIL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 222 TABLE 201 BRAZIL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 223 TABLE 202 BRAZIL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 223 TABLE 203 BRAZIL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 224 TABLE 204 BRAZIL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 224 TABLE 205 ARENTINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 225 TABLE 206 ARENTINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021-2035 (USD MILLION) 225 TABLE 207 ARENTINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY 2021-2035 (USD MILLION) 225 TABLE 208 ARENTINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION 2021-2035 (USD MILLION) 226 TABLE 209 ARENTINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021-2035 (USD MILLION) 226 TABLE 210 ARENTINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021-2035 (USD MILLION) 227 TABLE 211 ARENTINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021-2035 (USD MILLION) 227 TABLE 212 ARENTINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021-2035 (USD MILLION) 228 TABLE 213 ARENTINA FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021-2035 (USD MILLION) 228 TABLE 214 MEXICO FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021-2035 (USD MILLION) 229 LIST OF FIGURES FIGURE 1 FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET: STRUCTURE 37 FIGURE 2 FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET: STRUCTURE 38 FIGURE 3 MARKET DYNAMICS OVERVIEW FIGURE 4 DRIVERS IMPACT ANALYSIS: GLOBAL FLUOROPOLYMER BARRIER FILMS AND HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET FIGURE 5 RESTRAINT IMPACT ANALYSIS: GLOBAL FLUOROPOLYMER BARRIER FILMS AND HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET FIGURE 6 GLOBAL FLUOROPOLYMER BARRIER FILMS AND HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET: SUPPLY / VALUE CHAIN FIGURE 1 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2025 (% SHARE) FIGURE 2 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY MATERIAL TYPE, 2021–2035 (USD MILLION) FIGURE 3 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2025 (% SHARE) FIGURE 4 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PRODUCT TYPE, 2021–2035 (USD MILLION) FIGURE 5 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY, 2025 (% SHARE) FIGURE 6 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY TECHNOLOGY, 2021–2035 (USD MILLION) FIGURE 7 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION, 2025 (% SHARE) FIGURE 8 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY APPLICATION, 2021–2035 (USD MILLION) FIGURE 9 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2025 (% SHARE) FIGURE 10 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY BARRIER PERFORMANCE, 2021–2035 (USD MILLION) FIGURE 11 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2025 (% SHARE) 125 FIGURE 12 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY DRUG TYPE, 2021–2035 (USD MILLION) 125 FIGURE 13 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2025 (% SHARE) 129 FIGURE 14 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY END USER, 2021–2035 (USD MILLION) 129 FIGURE 15 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2025 (% SHARE) FIGURE 16 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY PACKAGING FORMAT, 2021–2035 (USD MILLION) FIGURE 17 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2025 (% SHARE) FIGURE 18 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY FUNCTIONALITY, 2021–2035 (USD MILLION) FIGURE 19 GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET, BY REGION, 2025 (% SHARE) FIGURE 20 COMPETITOR DASHBOARD: GLOBAL FLUOROPOLYMER BARRIER FILMS & HIGH-PERFORMANCE PHARMACEUTICAL PACKAGING MATERIALS MARKET PLAYERS FIGURE 21 DAIKIN INDUSTRIES: SWOT ANALYSIS FIGURE 22 SAINT-GOBAIN: SWOT ANALYSIS FIGURE 23 HONEYWELL INTERNATIONAL INC: SWOT ANALYSIS FIGURE 24 WEST PHARMACEUTICAL SERVICES, INC.: SWOT ANALYSIS FIGURE 25 ARKEMA: SWOT ANALYSIS FIGURE 26 GUARNIFLON® S.P.A: SWOT ANALYSIS FIGURE 27 TEKNI-PLEX, INC.: SWOT ANALYSIS FIGURE 28 ACG: SWOT ANALYSIS FIGURE 29 DUPONT: SWOT ANALYSIS FIGURE 30 CAPRIHANS INDIA LIMITED: SWOT ANALYSIS